Advances in pediatric asthma in 2013: Coordinating asthma care

Expression of Basophil Activation Markers in Pediatric Asthma

Background: Asthma is very common in children and its diagnosis is based on clinical manifestations, which can be misdiagnosed as other respiratory diseases with similar signs and symptoms. Objective: To analyze the expression of ST2L and CD203c in the diagnosis of pediatric asthma. Methods: Basophils were purified from whole blood samples of patients and healthy controls using Ficol-Paque grad...

Pediatric Asthma Care 1 Running Head: PEDIATRIC ASTHMA CARE Use of Information Technology to Improve Asthma Care in the Pediatric Population

Comorbidities of pediatric asthma: A narrative review

Background: Asthma is one of the most common persistent inflammatory respiratory disorders. Comorbidities are relatively common in asthma. The aim of this review study was to find comorbid disorders in children with asthma. Methods: For the purpose of this review, we searched databases including Scopus, Google scholar, PubMed, SID, Irandoc and up-to-date. Key words for the search included chil...

Recent advances in asthma.

There have recently been important advances in our understanding of asthma mechanisms and treatment. Asthma is now recognized as a disease of the airways which involves a special type of inflammation, characterized by the presence of activated mast cells, eosinophils and T-lymphocytes. There has been a growing recognition that chronic rather than acute inflammatory events are more relevant to u...

Pharmacoeconomics in pediatric asthma.

I n Canada throughout the 1990s, inhaled corticosteroids (ICS) have been the treatment of choice, and we continue to view ICS as the mainstay of treatment for persistent asthma in children, except for those whose disease is so mild that they only require infrequent, as-needed 2-agonist treatment.1 Corticosteroid dosage should continue to be individualized, and the minimum effective dose should ...